Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Studies in Health Technology and Informatics|August 8, 2013
Experience of de-identification system development for clinical research in tertiary hospitalSoo-Yong Shin, Yongman Lyu, Yongdon Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2009
Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancerJin Woo Song, Yeon-Mock Oh, Tae-Sun Shim, et al.
Thoracic Cancer|July 11, 2018
Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancerYunkyoung Lee, Sojung Park, Woo Sung Kim, et al.
The American Journal of Sports Medicine|May 1, 2009
Comparative evaluation of the measurement properties of various shoulder outcome instrumentsJoo Han Oh, Ki Hyun Jo, Woo Sung Kim, et al.
Healthcare Informatics Research|July 25, 2013
Lessons Learned from Development of De-identification System for Biomedical Research in a Korean Tertiary HospitalSoo-Yong Shin, Yongman Lyu, Yongdon Shin, et al.
Molecular Oncology|September 3, 2013
Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocationHyeong Ryul Kim, Woo Sung Kim, Yun Jung Choi, et al.
Neuroscience Letters|April 9, 2023
Differential effects of parental socioeconomic status on cortical thickness in patients with schizophrenia spectrum disorders and healthy controlsFatima Zahra Rami, Woo-Sung Kim, Jie Shen, et al.
Respiratory Medicine|December 4, 2012
The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosisKyung-Wook Jo, Wonjun Ji, Yoonki Hong, et al.
The Journal of Antimicrobial Chemotherapy|March 10, 2012
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patientsWon-Jung Koh, Yeh Rim Kang, Kyeonman Jeon, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancerSang-We Kim, Cheolwon Suh, Sang Do Lee, et al.
Pageof 19